EPIDESTINY
EpiDestiny develops non-cytotoxic epigenetic drugs that work with nature, not against it, to kindly and meaningfully treat sickle cell, thalassemia, and cancer
EPIDESTINY
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.epidestiny.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Official Site Inspections
http://www.epidestiny.com
- Host name: redirect2.proxy-ssl.webflow.com
- IP address: 34.193.69.252
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "EpiDestiny"
EpiDestiny Inc
EpiDestiny was founded in 2015 by Yogen Saunthararajah. As a physician-founded company, our driving principle is using science to meet severe unmet clinical needs, in a way that is kind and …See details»
EpiDestiny - Crunchbase Company Profile & Funding
Organization. EpiDestiny . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... EpiDestiny develops non-cytotoxic epigenetic drugs that …See details»
EpiDestiny Company Profile 2024: Valuation, Funding …
EpiDestiny General Information Description. Operator of a clinical-stage biotech company focused on developing rare hematology and oncology therapies The company specializes in developing non-toxic drugs that inhibit epigenetic …See details»
EpiDestiny Company Profile | Management and Employees List
EpiDestiny is a privately held, clinical stage biopharmaceutical company. Our goal is to spearhead a new era of gene control therapies that use small molecules to treat inherited and acquired …See details»
EpiDestiny, Inc. Company Profile | Akron, OH - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EpiDestiny, Inc. of Akron, OH. Get the latest business insights from Dun & Bradstreet.See details»
EpiDestiny Inc.: Contact Details and Business Profile - RocketReach
EpiDestiny Inc. is a Biotechnology, Venture Capital & Private Equity, and Pharmaceuticals company_reader located in Solon, Ohio with $1 million in revenue and 1 employees. Find top …See details»
EpiDestiny - Overview, News & Similar companies | ZoomInfo.com
Who is EpiDestiny. EpiDestiny is a privately held, clinical stage biopharmaceutical company. Our goal is to spearhead a new era of gene control therapies that use sma ll molecules to treat …See details»
Organization | EpiDestiny, Inc.
EpiDestiny, Inc. Report issue. For profit Phase 1. Founded: Cleveland OH United States (2016 ... Organization Overview. First Clinical Trial. 2019 NCT03828084. First Marketed Drug. None …See details»
EpiDestiny, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 23, 2023 Explore EpiDestiny, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, Disease Domain:Neoplasms, Hemic and Lymphatic Diseases ...See details»
EpiDestiny - Products, Competitors, Financials, Employees, …
EpiDestiny is a clinical stage biopharmaceutical company engaged in the discovery, development, and commercialization of therapies for rare genetic diseases such as Sickle Cell Anemia and …See details»
EpiDestiny - Crunchbase
EpiDestiny develops non-cytotoxic epigenetic drugs that work with nature.See details»
EPIDESTINY, INC. in Akron, OH | Company Information & Reviews
Dec 6, 2024 EPIDESTINY, INC. is an Ohio Corporation For-Profit filed on February 5, 2016. The company's filing status is listed as Active and its File Number is 3861257. The Registered …See details»
EpiDestiny - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. EpiDestiny . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 12. About. EpiDestiny is actively …See details»
Changing Gene Expression with a Pill: A New Treatment for Cancer …
Mar 24, 2020 A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... The EpiDestiny treatment turns these genes back …See details»
Changing Gene Expression with a Pill: A New Treatment for Cancer …
Jun 28, 2024 EpiDestiny found a way to treat patients without editing their genetic code. Instead, they their treatment harnesses epigenetics - how organisms change which genes are turned …See details»
Novo Nordisk gets rights to EpiDestiny’s blood disease drug
Novo Nordisk has obtained the exclusive worldwide licence for sickle cell disease (SCD) treatments being developed by US biotech company EpiDestiny. Under the deal, EpiDestiny …See details»
EpiDestiny - Contacts, Employees, Board Members, Advisors
Organization. EpiDestiny . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. EpiDestiny has 1 current …See details»
Novo Nordisk to Pay $400 Million to License EpiDestiny's Sickle …
Apr 9, 2018 Novo Nordisk agreed to pay an upfront fee of $400 million for an exclusive worldwide license for EpiDestiny program EPI01 in rare, genetic blood disorders Sickle Cell …See details»
Sickle Cell Disease Therapy Developer EpiDestiny Sells Rights to...
Apr 17, 2018 EpiDestiny recently completed a Phase 1 clinical trial (NCT01685515) to see if EPI01 could increase patients’ fetal hemoglobin levels and improve their sickle cell disease …See details»
Novo moves into sickle cell with $400M EpiDestiny deal
Apr 6, 2018 Novo Nordisk has moved into sickle cell disease through a licensing deal (PDF) with EpiDestiny. The $400 million deal gives Novo worldwide rights to an epigenetic treatment of …See details»